milrinone has been researched along with sulmazole in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (78.57) | 18.7374 |
| 1990's | 6 (21.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cazes, M; Cloarec, A; Fouquet, A; Güngör, T; Provost, D; Teulon, JM | 1 |
| Bobowski, G; Bristol, JA; Duell, BL; Evans, DB; Sircar, I | 1 |
| Decker, N; Leclerc, G; Marciniak, G; Schwartz, J | 1 |
| Bristol, JA; Evans, DB; Moos, WH; Sircar, I; Weishaar, RE | 1 |
| Coates, WJ; Connolly, B; Dhanak, D; Flynn, ST; Worby, A | 1 |
| Bethke, T; Klimkiewicz, A; Kohl, C; Mehl, H; Mende, U; Meyer, W; Neumann, J; Schmitz, W; Scholz, H; von der Leyen, H | 1 |
| Porsius, AJ; Post, MJ; te Biesebeek, JD; van Rooij, HH; Wemer, J | 4 |
| Böhm, M; Erdmann, E; Schwinger, RH; Ungerer, M | 1 |
| Blinks, JR; Endoh, M; Taira, N; Yanagisawa, T | 1 |
| Meyer, W; Scholz, H | 1 |
| Braunwald, E; Colucci, WS; Wright, RF | 1 |
| Ahn, HS; Eardley, D; Prioli, N; Watkins, R | 1 |
| Decker, N; Grima, M; Schwartz, J | 2 |
| Andersson, KE | 1 |
| Chiotti, D; Presbitero, P | 1 |
| Komajda, M | 1 |
| Colombo, F; Libretti, A | 1 |
| Tommaso, CL | 1 |
| Artman, M; Kithas, PA; Strada, SJ; Wike, JS | 1 |
| Endo, M; Kitada, Y; Matsumura, N; Narimatsu, A | 2 |
| Goldberg, LI | 1 |
| Carlier, J; D'Orio, V; el Allaf, D | 1 |
| Futaki, S; Goto, Y; Hata, K; Nishioka, T; Saeki, A; Suga, H; Takasago, T | 1 |
7 review(s) available for milrinone and sulmazole
| Article | Year |
|---|---|
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Administration, Oral; Aminopyridines; Amrinone; Cardiotonic Agents; Coenzymes; Enoximone; Heart; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Milrinone; Nifedipine; Oxyfedrine; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Quinazolines; Ubiquinone | 1986 |
Some new positive inotropic agents.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiotonic Agents; Dobutamine; Dopamine; Drug Tolerance; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Practolol; Prenalterol; Pyridones | 1986 |
[New inotropic drugs].
Topics: Adrenergic beta-Agonists; Amrinone; Cardiotonic Agents; Deoxyepinephrine; Enoximone; Ethanolamines; Heart; Humans; Imidazoles; Milrinone; Myocardial Contraction; Propanolamines; Pyridazines; Pyridones; Vasodilator Agents; Xamoterol | 1988 |
[Rational and irrational approach to the inotropic agent therapy of heart failure].
Topics: Amrinone; Cardiotonic Agents; Digitalis Glycosides; Heart Failure; Humans; Imidazoles; Milrinone; Pyridones; Vasodilator Agents | 1988 |
Non-glycoside, non-catecholamine inotropic agents in the treatment of congestive heart failure.
Topics: Administration, Oral; Aminopyridines; Amrinone; Arrhythmias, Cardiac; Calcium; Cardiac Output; Cardiotonic Agents; Cyclic AMP; Dose-Response Relationship, Drug; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Milrinone; Physical Exertion; Pyridones; Thrombocytopenia; Time Factors | 1986 |
Advances in cardiovascular pharmacology.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aminopyridines; Amrinone; Animals; Calcium Channel Blockers; Cardiovascular Agents; Dopamine; Heart Rate; Humans; Imidazoles; Milrinone; Myocardial Contraction; Pyridones; Receptors, Histamine; Vasodilator Agents | 1984 |
The new inotropic phosphodiesterase inhibitors.
Topics: Aminopyridines; Amrinone; Calcium; Carbamates; Cardiotonic Agents; Cardiovascular Agents; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridones; Quinazolines; Stimulation, Chemical; Time Factors; Xanthines | 1984 |
21 other study(ies) available for milrinone and sulmazole
| Article | Year |
|---|---|
Cardiotonic agents. Synthesis and cardiovascular properties of novel 2-arylbenzimidazoles and azabenzimidazoles.
Topics: Animals; Benzimidazoles; Cardiotonic Agents; Dogs; Female; Guinea Pigs; Heart Rate; Male; Models, Molecular; Myocardial Contraction; Rats; Structure-Activity Relationship | 1992 |
Cardiotonic agents. 2. Synthesis and structure-activity relationships of 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: a new class of positive inotropic agents.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Chemical Phenomena; Chemistry, Physical; Dogs; Heart Failure; Imidazoles; Myocardial Contraction; Pyridazines; Structure-Activity Relationship | 1985 |
Cardiotonic agents. 1. Synthesis and structure-activity relationships in a new class of 3-, 4-, and 5-pyridyl-2(1H)-quinolone derivatives.
Topics: Animals; Atrial Function; Cardiotonic Agents; Female; Guinea Pigs; Heart Atria; In Vitro Techniques; Indicators and Reagents; Magnetic Resonance Spectroscopy; Male; Myocardial Contraction; Pyridines; Quinolines; Structure-Activity Relationship | 1986 |
Cardiotonic agents. 1. 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3 (2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failure.
Topics: Animals; Cardiotonic Agents; Dogs; Guinea Pigs; Heart Failure; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridazines | 1984 |
Cyclic nucleotide phosphodiesterase inhibition by imidazopyridines: analogues of sulmazole and isomazole as inhibitors of the cGMP specific phosphodiesterase.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Imidazoles; Isoenzymes; Phosphodiesterase Inhibitors; Pyridines; Structure-Activity Relationship | 1993 |
Effects of isomazole on force of contraction and phosphodiesterase isoenzymes I-IV in nonfailing and failing human hearts.
Topics: Adult; Calcium; Chromatography, DEAE-Cellulose; Electric Stimulation; Female; Heart; Heart Failure; Humans; Imidazoles; In Vitro Techniques; Isoenzymes; Isoproterenol; Male; Middle Aged; Milrinone; Myocardial Contraction; Myocardium; Ouabain; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyridazines; Pyridones | 1991 |
Effects of milrinone, sulmazole and theophylline on adenosine enhancement of antigen-induced bronchoconstriction and mediator release in rat isolated lungs.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Adenosine; Animals; Antigens; Bronchoconstriction; Chromatography, High Pressure Liquid; Histamine Release; Imidazoles; In Vitro Techniques; Lung; Male; Milrinone; Perfusion; Pyridones; Rats; Rats, Inbred Strains; Serotonin; Theophylline | 1991 |
Antagonism of novel inotropic agents at A1 adenosine receptors and m-cholinoceptors in human myocardium.
Topics: Adult; Binding, Competitive; Cardiotonic Agents; Electric Stimulation; Guanylyl Imidodiphosphate; Heart; Heart Failure; Humans; Imidazoles; In Vitro Techniques; Membranes; Milrinone; Myocardium; Piperazines; Pyridazines; Pyridones; Quinuclidinyl Benzilate; Receptors, Cholinergic; Receptors, Purinergic; Xanthines | 1990 |
Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Aequorin; Aminopyridines; Amrinone; Animals; Calcium; Carbachol; Cardiotonic Agents; Colforsin; Cyclic AMP; Dogs; Dose-Response Relationship, Drug; Enoximone; Female; Imidazoles; Male; Milrinone; Myocardial Contraction; Myocardium; Nifedipine; Nucleotides, Cyclic; Pyrazines; Pyridones; Quinolines; Time Factors | 1986 |
Phosphodiesterase-inhibiting properties of newer inotropic agents.
Topics: 1-Methyl-3-isobutylxanthine; Aminopyridines; Amrinone; Animals; Calcium; Cardiotonic Agents; Cyclic AMP; Dose-Response Relationship, Drug; Guinea Pigs; Imidazoles; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Theophylline | 1986 |
Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Adenylyl Cyclases; Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Colforsin; Cyclic AMP; Enoximone; Guinea Pigs; Hydrolysis; Imidazoles; Isoenzymes; Milrinone; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Pyridones | 1986 |
Inhibition of some new cardiotonic agents by tetrodotoxin.
Topics: Animals; Cardiotonic Agents; Dihydropyridines; Dose-Response Relationship, Drug; Guinea Pigs; Heart Atria; Imidazoles; In Vitro Techniques; Ion Channels; Isoproterenol; Milrinone; Myocardial Contraction; Protoveratrines; Pyridines; Pyridones; Quinazolines; Tetrodotoxin | 1986 |
Anti-allergic effects of milrinone and sulmazole in isolated rat lungs in comparison with theophylline.
Topics: Airway Resistance; Animals; Histamine Release; Imidazoles; In Vitro Techniques; Leukotrienes; Lung; Male; Milrinone; Phosphodiesterase Inhibitors; Pulmonary Circulation; Pyridones; Rats; Rats, Inbred Strains; Serotonin; Theophylline; Vasoconstriction | 1989 |
In vivo anaphylaxis in the rat: effects of phosphodiesterase inhibitors.
Topics: Anaphylaxis; Animals; Antigens; Cardiovascular System; Imidazoles; Lung; Male; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Rats; Rats, Inbred Strains; Theophylline | 1989 |
Comparison of the anti-anaphylactic effects of milrinone, sulmazole and theophylline in the rat.
Topics: Acid-Base Equilibrium; Airway Resistance; Anaphylaxis; Animals; Imidazoles; Lung Compliance; Male; Milrinone; Phosphodiesterase Inhibitors; Pulmonary Circulation; Pyridones; Rats; Rats, Inbred Strains; Theophylline; Vasoconstriction | 1989 |
[New cardiotonic agents].
Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Colforsin; Deoxyepinephrine; Humans; Imidazoles; Levodopa; Milrinone; Practolol; Prenalterol; Propanolamines; Pyridones; Quinazolines; Xamoterol | 1985 |
Inotropic responses change during postnatal maturation in rabbit.
Topics: Aging; Animals; Animals, Newborn; Cardiotonic Agents; Colforsin; Female; Heart; Imidazoles; Isoproterenol; Male; Milrinone; Myocardial Contraction; Pyridones; Rabbits; Reference Values; Software | 1988 |
Increase in Ca++ sensitivity of the contractile system by MCI-154, a novel cardiotonic agent, in chemically skinned fibers from the guinea pig papillary muscles.
Topics: Adenosine Triphosphate; Animals; Calcium; Cardiotonic Agents; Guinea Pigs; Imidazoles; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Papillary Muscles; Pyridazines; Pyridones; Sarcoplasmic Reticulum | 1987 |
Contractile proteins: possible targets for the cardiotonic action of MCI-154, a novel cardiotonic agent?
Topics: Animals; Cardiotonic Agents; Contractile Proteins; Guinea Pigs; Imidazoles; In Vitro Techniques; Milrinone; Myocardial Contraction; Papillary Muscles; Pyridazines; Pyridones | 1987 |
Effect of some new cardiotonic agents on synaptosomal sodium uptake.
Topics: Animals; Cardiotonic Agents; Guinea Pigs; Heart Atria; Imidazoles; Male; Milrinone; Protoveratrines; Pyridones; Quinazolines; Rats; Rats, Inbred Strains; Sodium; Synaptosomes; Tetrodotoxin; Theophylline; Time Factors | 1986 |
Effects of milrinone and sulmazole on left ventricular mechanoenergetics in canine hearts.
Topics: Animals; Cardiotonic Agents; Dogs; Heart; Imidazoles; Milrinone; Myocardial Contraction; Oxygen Consumption; Phosphodiesterase Inhibitors; Pyridones; Stimulation, Chemical; Ventricular Function, Left; Ventricular Pressure | 1996 |